Details for Patent: 7,947,295
✉ Email this page to a colleague
Which drugs does patent 7,947,295 protect, and when does it expire?
Patent 7,947,295 protects ILEVRO and is included in one NDA.
This patent has forty patent family members in sixteen countries.
Summary for Patent: 7,947,295
Title: | Ophthalmic compositions containing a synergistic combination of two polymers |
Abstract: | Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of two polymers that have a synergistic effect on viscosity. |
Inventor(s): | Chowhan; Masood A. (Arlington, TX), Chen; Huagang (Arlington, TX) |
Assignee: | Alcon, Inc. (Hunenberg, CH) |
Application Number: | 11/673,070 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,947,295 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 7,947,295
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ILEVRO | nepafenac | SUSPENSION/DROPS;OPHTHALMIC | 203491-001 | Oct 16, 2012 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,947,295
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2004249137 | ⤷ Sign Up | |||
Australia | 2010200297 | ⤷ Sign Up | |||
Australia | 2012205283 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |